On the public citation graph
Biomarkers of neoadjuvant/adjuvant chemotherapy for breast cancer
0 signed · 127 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/s10549-011-1706-9openalex-snapshot
First generation prognostic gene signatures for breast cancer predict both survival and chemotherapy sensitivity and identify overlapping patient populations
inferredcites →https://doi.org/10.1007/s10549-017-4358-6openalex-snapshot
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
inferredcites →https://doi.org/10.1007/s10549-017-4502-3openalex-snapshot
Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer
inferredcites →https://doi.org/10.1007/s10549-018-4981-xopenalex-snapshot
A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients
inferredcites →https://doi.org/10.1016/j.clbc.2015.10.004openalex-snapshot
Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor–Positive, HER2-Negative Breast Cancer
inferredcites →https://doi.org/10.1016/s0140-6736(13)62422-8openalex-snapshot
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
inferredcites →https://doi.org/10.1016/s1043-321x(05)80232-2openalex-snapshot
3–34 A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
inferredcites →https://doi.org/10.1016/s1043-321x(07)80280-3openalex-snapshot
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
inferredcites →https://doi.org/10.1016/s1470-2045(09)70314-6openalex-snapshot
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
inferredcites →https://doi.org/10.1016/s1470-2045(19)30158-5openalex-snapshot
Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers
inferredcites →https://doi.org/10.1038/35021093openalex-snapshot
Molecular portraits of human breast tumours
inferredcites →https://doi.org/10.1038/415530aopenalex-snapshot
Gene expression profiling predicts clinical outcome of breast cancer
inferredcites →https://doi.org/10.1038/clpt.2010.245openalex-snapshot
Acceptance of Biomarker-Based Tests for Application in Clinical Practice: Criteria and Obstacles
inferredcites →https://doi.org/10.1038/news020128-6openalex-snapshot
Gene expression profiling predicts clinical outcome of breast cancer
inferredcites →https://doi.org/10.1038/s41523-017-0033-7openalex-snapshot
Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry
inferredcites →https://doi.org/10.1056/nejmoa041588openalex-snapshot
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa052933openalex-snapshot
Concordance among Gene-Expression–Based Predictors for Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa1510764openalex-snapshot
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa1602253openalex-snapshot
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa1612645openalex-snapshot
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
inferredcites →https://doi.org/10.1056/nejmoa1804710openalex-snapshot
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
inferredcites →https://doi.org/10.1056/nejmoa1814017openalex-snapshot
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
inferredcites →https://doi.org/10.1056/nejmra0801289openalex-snapshot
Gene-Expression Signatures in Breast Cancer
inferredcites →https://doi.org/10.1073/pnas.0932692100openalex-snapshot
Repeated observation of breast tumor subtypes in independent gene expression data sets
inferredcites →https://doi.org/10.1093/annonc/mdu112openalex-snapshot
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
inferredcites →https://doi.org/10.1093/annonc/mdu450openalex-snapshot
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
inferredcites →https://doi.org/10.1093/annonc/mdv221openalex-snapshot
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
inferredcites →https://doi.org/10.1093/jnci/djj329openalex-snapshot
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
inferredcites →https://doi.org/10.1093/jnci/djp335openalex-snapshot
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
inferredcites →https://doi.org/10.1093/jnci/djq524openalex-snapshot
Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-10-1045openalex-snapshot
Distinct p53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers
inferredcites →https://doi.org/10.1158/1078-0432.ccr-12-1000openalex-snapshot
Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
inferredcites →https://doi.org/10.1200/jco.1998.16.1.93openalex-snapshot
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.
inferredcites →https://doi.org/10.1200/jco.1998.16.8.2672openalex-snapshot
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
inferredcites →https://doi.org/10.1200/jco.2007.10.6823openalex-snapshot
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
inferredcites →https://doi.org/10.1200/jco.2007.15.1068openalex-snapshot
Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials
inferredcites →https://doi.org/10.1200/jco.2011.41.0902openalex-snapshot
Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
inferredcites →https://doi.org/10.1200/jco.2013.55.0491openalex-snapshot
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
inferredcites →https://doi.org/10.1200/jco.2014.58.1967openalex-snapshot
Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers
inferredcites →https://doi.org/10.1200/jco.2015.63.1010openalex-snapshot
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
inferredcites →https://doi.org/10.1200/jco.2015.63.3651openalex-snapshot
Biomarker: Predictive or Prognostic?
inferredcites →https://doi.org/10.1200/jco.2015.65.2289openalex-snapshot
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
inferredcites →https://doi.org/10.1200/jco.2017.74.0472openalex-snapshot
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
inferredcites →https://doi.org/10.1200/jco.22.02571openalex-snapshot
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
inferredcites →https://doi.org/10.1371/journal.pone.0115103openalex-snapshot
The Value of Tumor Infiltrating Lymphocytes (TILs) for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4087372openalex-extracted
Soluble Periostin is a Potential Biomarker for Chemotherapy Efficacy Monitoring in Advanced Breast Cancer
inferred← citeshttps://doi.org/10.1002/jmri.27910openalex-snapshot
Evaluating Tumor‐Infiltrating Lymphocytes in Breast Cancer Using Preoperative MRI ‐Based Radiomics
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_324-1openalex-snapshot
Role of Tumor Markers in Early Detection and Prevention of Complications in Oncology
inferred← citeshttps://doi.org/10.1007/978-3-032-00775-9_324openalex-snapshot
Role of Tumor Markers in Early Detection and Prevention of Complications in Oncology
inferred← citeshttps://doi.org/10.1007/s10238-026-02162-yopenalex-snapshot
Predictors of pathologic complete response in triple‑negative breast cancer treated with neoadjuvant chemotherapy: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s11033-026-12512-4openalex-snapshot
Determinants of response to neoadjuvant chemotherapy in breast cancer: Integrated roles of immune pathways, DNA damage response, and cell cycle regulators
inferred← citeshttps://doi.org/10.1007/s12033-023-01029-xopenalex-snapshot
Expression Significance of Estrogen Receptor ER-α36 in Breast Cancer Treated by Chemotherapy: A Meta-Analysis
inferred← citeshttps://doi.org/10.1007/s12094-025-03856-7openalex-snapshot
Predictive score for response to neoadjuvant chemotherapy in early-stage HR + /HER2− breast cancer
inferred← citeshttps://doi.org/10.1007/s13402-023-00862-1openalex-snapshot
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer
inferred← citeshttps://doi.org/10.1016/j.acra.2026.02.001openalex-snapshot
Value of Dual-Energy Computed Tomography Quantitative Parameters in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
inferred← citeshttps://doi.org/10.1016/j.adcanc.2023.100113openalex-snapshot
Neutrophil to lymphocyte ratio does not behave as a good predictor of pathological complete response in breast cancer: A retrospective analysis in the neoadjuvant setting
inferred← citeshttps://doi.org/10.1016/j.clbc.2023.03.007openalex-snapshot
Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics
inferred← citeshttps://doi.org/10.1016/j.clbc.2023.06.004openalex-snapshot
A Review of AI-Based Radiomics and Computational Pathology Approaches in Triple-Negative Breast Cancer: Current Applications and Perspectives
inferred← citeshttps://doi.org/10.1016/j.cvsm.2023.12.008openalex-snapshot
Noninvasive Blood-Based Cancer Detection in Veterinary Medicine
inferred← citeshttps://doi.org/10.1016/j.ejso.2024.108351openalex-snapshot
Third national surgical consensus conference of the Italian Association of Breast Surgeons (ANISC) on management after neoadjuvant chemotherapy: The difficulty in reaching a consensus
inferred← citeshttps://doi.org/10.1016/j.isci.2024.110682openalex-snapshot
Multi-omic analysis identifies metabolic biomarkers for the early detection of breast cancer and therapeutic response prediction
inferred← citeshttps://doi.org/10.1016/j.jrras.2023.100692openalex-snapshot
The role of aspirin in with breast cancer patients receiving neoadjuvant chemotherapy by targeting JAK2/ STAT3
inferred← citeshttps://doi.org/10.1016/j.omton.2025.200982openalex-snapshot
hsa-miR-5688 inhibits FOXC1-OCT4/SOX2 feedforward loop that drives chemoresistance in breast cancer stem cells
inferred← citeshttps://doi.org/10.1016/j.prp.2022.153915openalex-snapshot
Increased LZTS1 expression is associated with a good response to paclitaxel-based chemotherapy in breast cancer
inferred← citeshttps://doi.org/10.1021/acs.analchem.4c05833openalex-snapshot
Raman Spectroscopy and Exosome-Based Machine Learning Predicts the Efficacy of Neoadjuvant Therapy for HER2-Positive Breast Cancer
inferred← citeshttps://doi.org/10.1021/acs.jproteome.0c00362openalex-snapshot
Investigating the Association of the Biogenic Amine Profile in Urine with Therapeutic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
inferred← citeshttps://doi.org/10.1038/s41416-023-02215-zopenalex-snapshot
Artificial intelligence: opportunities and challenges in the clinical applications of triple-negative breast cancer
inferred← citeshttps://doi.org/10.1038/s41598-023-41836-5openalex-snapshot
Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer
inferred← citeshttps://doi.org/10.1038/s41598-023-43414-1openalex-snapshot
Disulfidptosis-associated lncRNAs predict breast cancer subtypes
inferred← citeshttps://doi.org/10.1038/s41598-024-69546-6openalex-snapshot
Impact of neoadjuvant chemotherapy on perioperative immune function in breast cancer patients: a propensity score-matched retrospective study
inferred← citeshttps://doi.org/10.1080/21645515.2025.2527450openalex-snapshot
Research hotspots and trends in tumor vaccine adjuvants: A bibliometric analysis from 2010 to 2024
inferred← citeshttps://doi.org/10.1097/cad.0000000000001551openalex-snapshot
Mechanism of gemcitabine combined with lobaplatin in interventional treatment of locally advanced cervical cancer
inferred← citeshttps://doi.org/10.1097/js9.0000000000001123openalex-snapshot
SKA3 targeted therapies in cancer precision surgery: bridging bench discoveries to clinical applications – review article
inferred← citeshttps://doi.org/10.1097/md.0000000000044052openalex-snapshot
Comparison of tumor clipping and marking of skin projection methods in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy: A randomized controlled trial
inferred← citeshttps://doi.org/10.1134/s1990750824600559openalex-snapshot
Changes in the Expression Landscape of HER2-Negative Breast Cancer under the Influence of Anthracycline-Containing Neoadjuvant Chemotherapy Regimens
inferred← citeshttps://doi.org/10.1155/2022/3254581openalex-snapshot
Controlling Nutritional Status (CONUT) as a Novel Postoperative Prognostic Marker in Breast Cancer Patients: A Retrospective Study
inferred← citeshttps://doi.org/10.1155/2022/7847889openalex-snapshot
Neoadjuvant Chemotherapy Combined with Breast-Conserving Surgery in the Treatment of Triple-Negative Breast Cancer
inferred← citeshttps://doi.org/10.1155/2022/8685680openalex-snapshot
MRI Images‐Based Evaluation of Efficacy of Neoadjuvant Chemotherapy for Breast Cancer and Its Effect on Depression and Immune Function of Patients
inferred← citeshttps://doi.org/10.1155/2022/9998114openalex-snapshot
Effectiveness and Safety of Zercepac and Reference Trastuzumab in the Neoadjuvant Setting for Early-Stage Breast Cancer: A Retrospective Cohort Study
inferred← citeshttps://doi.org/10.1155/2023/3077180openalex-snapshot
The Role of Nomogram Based on the Combination of Ultrasound Parameters and Clinical Indicators in the Degree of Pathological Remission of Breast Cancer
inferred← citeshttps://doi.org/10.1186/s12885-023-10558-2openalex-snapshot
CD1C is associated with breast cancer prognosis and immune infiltrates
inferred← citeshttps://doi.org/10.1186/s12920-023-01748-9openalex-snapshot
RETRACTED ARTICLE: A novel necroptosis signature for predicting survival in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1186/s12935-024-03298-1openalex-snapshot
Soluble Periostin is a potential surveillance biomarker for early and long-term response to chemotherapy in advanced breast cancer
inferred← citeshttps://doi.org/10.1186/s13058-023-01747-9openalex-snapshot
Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a propensity-score-matched cohort study
inferred← citeshttps://doi.org/10.12669/pjms.38.3.5199openalex-snapshot
Clinical curative effect of neoadjuvant chemotherapy combined with immunotherapy and its impact on immunological function and the expression of ER, PR, HER-2 & SATB1 in HER-2-Positive breast cancer patients
inferred← citeshttps://doi.org/10.1371/journal.pone.0299138openalex-snapshot
Cuproptosis-associated ncRNAs predict breast cancer subtypes
inferred← citeshttps://doi.org/10.1590/1806-9282.20241225openalex-snapshot
Tumor-stroma type and tumor-stroma ratio predict neoadjuvant chemotherapy response in breast cancer
inferred← citeshttps://doi.org/10.21203/rs.3.rs-8937161/v1openalex-snapshot
Integrated bioinformatics analysis reveals ISG15, IFIH1, OAS2, MX1, and CXCL10 as predictive biomarkers of neoadjuvant chemotherapy response in triple-negative breast cancer
inferred← citeshttps://doi.org/10.2147/bctt.s418376openalex-snapshot
ABVS-Based Radiomics for Early Predicting the Efficacy of Neoadjuvant Chemotherapy in Patients with Breast Cancers
inferred← citeshttps://doi.org/10.21577/0103-5053.20230128openalex-snapshot
Advances in Breast Cancer Drug Discovery: A Review of Therapeutic Strategies and Studies Involving Photosensitizers, Caged Xanthones and Thiosemicarbazones Derivatives
inferred← citeshttps://doi.org/10.31243/ei.uta.v7i4.1871.2022openalex-snapshot
EPIDEMIOLOGÍA Y NUEVAS DIANAS MOLECULARES EN CÁNCER DE MAMA
inferred← citeshttps://doi.org/10.31557/apjcp.2023.24.2.401openalex-snapshot
Value of Conventional MRI, DCE-MRI, and DWI-MRI in the Discrimination of Metastatic from Non-Metastatic Lymph Nodes in Rectal Cancer: A Systematic Review and Meta-Analysis Study
inferred← citeshttps://doi.org/10.31557/apjcp.2023.24.2.525openalex-snapshot
Prevalence of Pathogenic Germline Mutations in 13 Hereditary Cancer-Related Genes in Breast Cancer Patients in Narathiwat Province, Thailand
inferred← citeshttps://doi.org/10.31584/jhsmr.2022911openalex-snapshot
Survival Outcomes in Breast Cancer Patients and Associated Factors in a Border Province of Thailand: A Hospital-based Review
inferred← citeshttps://doi.org/10.3233/thc-240695openalex-snapshot
The intervention effect of psychological care combined with ondansetron, dexamethasone, and promethazine hydrochloride on chemotherapy in breast cancer surgical patients
inferred← citeshttps://doi.org/10.3389/fgene.2022.991706openalex-snapshot
A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survival
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1851289openalex-snapshot
Biomarker-driven neoadjuvant immunotherapy in triple-negative breast cancer: emerging therapeutic targets FOXP3 and WT1
inferred← citeshttps://doi.org/10.3389/fmed.2025.1631621openalex-snapshot
Case Report: Comparison different response after neoadjuvant chemotherapy of the breast with cell-in-cell—report of two cases
inferred← citeshttps://doi.org/10.3389/fonc.2023.1143163openalex-snapshot
Intra-tumoral microbial community profiling and associated metabolites alterations of TNBC
inferred← citeshttps://doi.org/10.3389/fvets.2023.1179808openalex-snapshot
GATA-3 expression and its correlation with prognostic factors and survival in canine mammary tumors
inferred← citeshttps://doi.org/10.3390/cancers17101619openalex-snapshot
Personalizing Neoadjuvant Chemotherapy: The Impact of BRCA Variants on Pathologic Complete Response in Luminal B Breast Cancer
inferred← citeshttps://doi.org/10.3390/cancers18071107openalex-snapshot
Prognostic Potential of the NRF2 Transcription Factor in Canine Mammary Neoplasms
inferred← citeshttps://doi.org/10.3390/cancers18132065openalex-snapshot
Tumor-Infiltrating Lymphocytes as Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer: Added Value of Morphological Characterization Beyond Quantification
inferred← citeshttps://doi.org/10.3390/curroncol29070389openalex-snapshot
Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?
inferred← citeshttps://doi.org/10.3390/ijms24129984openalex-snapshot
Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer
inferred← citeshttps://doi.org/10.3390/jpm16010049openalex-snapshot
Post-NAC Microcalcifications in Breast Cancer: Rethinking Surgical Indications in the Era of Precision Oncology
inferred← citeshttps://doi.org/10.36557/2674-8169.2024v6n5p2278-2295openalex-snapshot
AVANÇOS EM MARCADORES TUMORAIS NO DIAGNÓSTICO E TRATAMENTO DO CÂNCER DE MAMA
inferred← citeshttps://doi.org/10.36899/japs.2025.2.0052openalex-snapshot
Effect of Vascular Endothelial Growth Factor siRNA-loaded Nanoparticles with Doxorubicin in Inhibiting the Growth of Breast Cancer in Xenograft Mouse Model
inferred← citeshttps://doi.org/10.47750/jptcp.2023.30.03.026openalex-snapshot
Investigation of CD73 expression in Iraqi patient women with breast tumors
inferred← citeshttps://doi.org/10.5603/ocp.99779openalex-snapshot
Novel biomarkers in bone sarcomas — diagnosis, treatment selection, and clinical trials
inferred← citeshttps://doi.org/10.5772/intechopen.1007670openalex-snapshot
Precision Medicine Approaches in Breast Cancer: Current Strategies and Future Directions
inferred← citeshttps://doi.org/10.6084/m9.figshare.22613746openalex-snapshot
Additional file 1 of CD1C is associated with breast cancer prognosis and immune infiltrates
inferred← citeshttps://doi.org/10.6084/m9.figshare.24655898openalex-snapshot
Additional file 1 of A novel necroptosis signature for predicting survival in lung adenocarcinoma
inferred← citeshttps://doi.org/10.6084/m9.figshare.24656142openalex-snapshot
Additional file 2 of A novel necroptosis signature for predicting survival in lung adenocarcinoma
inferred← citeshttps://doi.org/10.6084/m9.figshare.25440929openalex-snapshot
Additional file 1 of Soluble Periostin is a potential surveillance biomarker for early and long-term response to chemotherapy in advanced breast cancer
inferred← citeshttps://doi.org/10.6084/m9.figshare.25441047openalex-snapshot
Additional file 2 of Soluble Periostin is a potential surveillance biomarker for early and long-term response to chemotherapy in advanced breast cancer
inferred← citeshttps://doi.org/10.6084/m9.figshare.26646481openalex-snapshot
Additional file 3 of A novel necroptosis signature for predicting survival in lung adenocarcinoma
inferred← citeshttps://doi.org/10.6084/m9.figshare.26695491openalex-snapshot
Additional file 3 of Soluble Periostin is a potential surveillance biomarker for early and long-term response to chemotherapy in advanced breast cancer
inferred← citeshttps://doi.org/10.6084/m9.figshare.26695494openalex-snapshot
Additional file 4 of Soluble Periostin is a potential surveillance biomarker for early and long-term response to chemotherapy in advanced breast cancer
inferred← citeshttps://doi.org/10.6084/m9.figshare.26695497openalex-snapshot
Additional file 5 of Soluble Periostin is a potential surveillance biomarker for early and long-term response to chemotherapy in advanced breast cancer
inferred← citeshttps://doi.org/10.6084/m9.figshare.26695500openalex-snapshot
Additional file 6 of Soluble Periostin is a potential surveillance biomarker for early and long-term response to chemotherapy in advanced breast cancer
inferred← citeshttps://doi.org/10.6084/m9.figshare.26695503openalex-snapshot
Additional file 7 of Soluble Periostin is a potential surveillance biomarker for early and long-term response to chemotherapy in advanced breast cancer
inferred← citeshttps://doi.org/10.62347/upbl4602openalex-snapshot
Application value of Neuman’s nursing model in the perioperative period of radical mastectomy
inferred← citeshttps://doi.org/10.62347/xlcy5727openalex-snapshot
IGLL5 has potential to be a prognostic biomarker and its correlation with immune infiltrates in breast cancer
inferred← citeshttps://doi.org/10.7759/cureus.107973openalex-snapshot
Residual Primary Breast Cancer After Chemotherapy: Assessment of Recurrence and Survival
inferred← citeshttps://doi.org/10.7759/cureus.49742openalex-snapshot
The Current Role of Neoadjuvant Chemotherapy in the Management of HER2-Positive, Triple-Negative, and Micropapillary Breast Cancer: A Narrative Review
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.